Comparison of the Efficacy, Safety, Pharmacokinetic and Immunogenicity of UJVIRA (ZRC-3256, Trastuzumab Emtansine) With the Kadcyla (Trastuzumab Emtansine) in the Treatment of HER2-Positive Metastatic Breast Cancer: A Randomized, Open-Label, Multicenter Study in India
Satheesh Chiradoni Thungappa, Tanveer Maksud, Nirmal Vivek Raut, Rajnish Nagarkar, Ullas Batra, Sanjeev Kumar, Dhruvanshu Parmar
Topics & Concepts
MedicinePharmacokineticsTrastuzumabMetastatic breast cancerImmunogenicityOncologyBreast cancerTrastuzumab emtansineBioequivalenceInternal medicineRandomized controlled trialPharmacologyClinical trialAdverse effectCancerAntibodyImmunologyHER2/EGFR in Cancer ResearchBiosimilars and Bioanalytical MethodsMonoclonal and Polyclonal Antibodies Research